Work

Annexin A2 is a new antigenic target for pancreatic cancer immunotherapy

Year: 2012

Type: article

Abstract: In our recent publication (Zheng et al., PLoS ONE) we described the identification of annexin A2 as a new pancreatic cancer associated tumor antigen. Its involvement in pancreatic cancer progression and metastases supports its role as an antigenic target for the development of both therapeutic antibody and T cell immunotherapy.

Source: OncoImmunology

DOI: 10.4161/onci.1.1.18017

Authors: Lei Zheng, Elizabeth M. Jaffee

Institutions: Johns Hopkins University, Sidney Kimmel Cancer Center, Johns Hopkins Hospital, Sidney Kimmel Comprehensive Cancer Center

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,913